Related Experiment Video
Updated: Jun 28, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Tautomycetin suppresses the TNFalpha/NF-kappaB pathway via inhibition of IKK activation
Shinya Mitsuhashi1, Hiroshi Shima, Ying Li
1Division of Biochemical Oncology and Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo 060-0815, Japan.
Abstract:
TNFalpha activated NF-kappaB and associated regulatory factors including IKK are strongly implicated in a variety of hematological and solid tumor malignancies. We show that tautomycetin (TC) specifically inhibits activation of NF-kappaB among the three TNFalpha effectors (NF-kappaB, JNK and caspase). TC inhibited T-loop phosphorylation of IKKalpha and IKKbeta, thereby preventing degradation of the NF-kappaB inhibitor, IkappaBalpha. Co-immunoprecipitation experiments revealed that the catalytic subunit of PP1 (PP1C) was involved in the IKK complex. Pull-down analysis using recombinant GST-TNFalpha, showed that PP1C was recruited to TNFR1 together with IKK complex, RIP and TAK1 upon stimulus. These results suggest that the PP1 positively regulates the TNFalpha-induced NF-kappaB pathway at the level of IKK activation. Thus, TC might be used therapeutically to suppress the TNFalpha/NF-kappaB pathway.
Insights
Tautomycetin (TC) inhibits the Tumor Necrosis Factor-alpha (TNFalpha)-induced Nuclear Factor-kappaB (NF-kappaB) pathway by targeting IKK activation. This suggests TC as a potential therapeutic to suppress cancer-promoting signaling.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Tumor Necrosis Factor-alpha (TNFalpha) signaling activates Nuclear Factor-kappaB (NF-kappaB), a key pathway implicated in various hematological and solid tumors.
- Inhibitor of kappaB kinase (IKK) is a critical regulator in the TNFalpha-NF-kappaB pathway.
Purpose of the Study:
- To investigate the specific inhibitory effects of tautomycetin (TC) on TNFalpha-induced NF-kappaB activation.
- To elucidate the molecular mechanism by which TC modulates the NF-kappaB pathway.
Main Methods:
- Treatment with tautomycetin (TC) to assess its effect on NF-kappaB activation.
- Analysis of T-loop phosphorylation of IKKalpha and IKKbeta.
- Co-immunoprecipitation and pull-down assays to identify protein interactions within the TNFalpha signaling complex.
Main Results:
- Tautomycetin (TC) specifically inhibited NF-kappaB activation among TNFalpha effectors (NF-kappaB, JNK, caspase).
- TC blocked T-loop phosphorylation of IKKalpha and IKKbeta, preventing IkappaBalpha degradation.
- Protein phosphatase 1 catalytic subunit (PP1C) was identified as part of the IKK complex and recruited to TNFR1, positively regulating TNFalpha-induced NF-kappaB activation.
Conclusions:
- Protein phosphatase 1 (PP1) positively regulates TNFalpha-induced NF-kappaB pathway activation at the IKK level.
- Tautomycetin (TC) demonstrates therapeutic potential for suppressing the TNFalpha/NF-kappaB pathway in malignancies.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...